Evidence map›Paper›PMID 30003430›Full record

ArticleJournal of molecular neuroscience : MN2018

Transplantation of Human-Induced Pluripotent Stem Cell-Derived Neural Precursors into Early-Stage Zebrafish Embryos.

J Strnadel, H Wang, C Carromeu, A Miyanohara, K Fujimura, E Blahovcova, V Nosal, H Skovierova, R Klemke, E Halasova

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular neuroscience : MN, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. One Host-Multiple Applications: Zebrafish (International journal of molecular sciences · 2022
    Review
  3. Review
  4. Leveraging the zebrafish to model organ transplantation.Current opinion in organ transplantation · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

J StrnadelDepartment of Pathology, University of California, 9500 Gilman Drive # 0612, La Jolla, CA, 92093, USA. strnadel@jfmed.uniba.sk.ORCID http://orcid.org/0000-0002-7233-6537
H WangDepartment of Pathology, University of California, 9500 Gilman Drive # 0612, La Jolla, CA, 92093, USA.
C CarromeuDepartment of Pediatrics, University of California, 9500 Gilman Drive # 0612, La Jolla, CA, 92093, USA.
A MiyanoharaDepartment of Anesthesiology, University of California, 9500 Gilman Drive # 0612, La Jolla, CA, 92093, USA.
K FujimuraDepartment of Pathology, University of California, 9500 Gilman Drive # 0612, La Jolla, CA, 92093, USA.
E BlahovcovaDepartment of Molecular Medicine, Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 036 01, Bratislava, Slovakia.
V NosalDepartment of Molecular Medicine, Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 036 01, Bratislava, Slovakia.
H SkovierovaDepartment of Molecular Medicine, Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 036 01, Bratislava, Slovakia.
R KlemkeDepartment of Pathology, University of California, 9500 Gilman Drive # 0612, La Jolla, CA, 92093, USA.
E HalasovaDepartment of Molecular Medicine, Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Mala Hora 4C, 036 01, Bratislava, Slovakia.
University of California San Diego · USComenius University Bratislava · SK

Funding

National Cancer Institute NIH-NHLBI: 5PO1HL066941National Institutes of Health CA184596
6 · The paper itself

Abstract

Induced pluripotent stem cells (iPS cells) generated from somatic cells through reprogramming hold great promises for regenerative medicine. However, how reprogrammed cells survive, behave in vivo, and interact with host cells after transplantation still remains to be addressed. There is a significant need for animal models that allow in vivo tracking of transplanted cells in real time. In this regard, the zebrafish, a tropical freshwater fish, provides significant advantage as it is optically transparent and can be imaged in high resolution using confocal microscopy. The principal goal of this study was to optimize the protocol for successful short-term and immunosuppression-free transplantation of human iPS cell-derived neural progenitor cells into zebrafish and to test their ability to differentiate in this animal model. To address this aim, we isolated human iPS cell-derived neural progenitor cells from human fibroblasts and grafted them into (a) early (blastocyst)-stage wild-type AB zebrafish embryos or (b) 3-day-old Tg(gfap:GFP) zebrafish embryos (intracranial injection). We found that transplanted human neuronal progenitor cells can be effectively grafted and that they differentiate and survive in zebrafish for more than 2 weeks, validating the model as an ideal platform for in vivo screening experiments. We conclude that zebrafish provides an excellent model for studying iPS cell-derived cells in vivo.

Indexed as

AnimalsBlastocystCells, CulturedHumansInduced Pluripotent Stem CellsNeural Stem CellsStem Cell TransplantationZebrafishCell graftingHuman iPS cellsiPS cell-derived neural precursorsZebrafish

Identifiers

PMID30003430
OpenAlexW2827849192

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.